During the past decade, NYU Hospital for Joint Diseases conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 23 clinical trials were completed, i.e. on average, 115% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NYU Hospital for Joint Diseases" #1 sponsor was "NYU Langone Health" with 17 trials, followed by "Allergan" with 4 trials sponsored, "Smith & Nephew, Inc." with 4 trials sponsored, "Boston Medical Center" with 3 trials sponsored and "Dartmouth-Hitchcock Medical Center" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Hospital for Joint Diseases" #1 collaborator was "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 9 trials as a collaborator, "Office of Research on Women's Health (ORWH)" with 5 trials as a collaborator, "DePuy Spine" with 3 trials as a collaborator, "National Institute for Occupational Safety and Health (NIOSH/CDC)" with 3 trials as a collaborator and "K2M, Inc." with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "NYU Hospital for Joint Diseases" are "Osteoarthritis" (7 trials), "Cerebral Palsy" (5 trials), "Systemic Lupus Erythematosus" (5 trials), "Muscle Spasticity" (4 trials) and "Pediatrics" (4 trials). Many other conditions were trialed in "NYU Hospital for Joint Diseases" in a lesser frequency.

Most popular intervention types in "NYU Hospital for Joint Diseases" are "Drug" (27 trials), "Device" (17 trials), "Procedure" (14 trials), "Biological" (7 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Non-surgical treatments" (3 trials), "Botulinum Toxin Type A" (2 trials), "Decompressive laminectomy" (2 trials) and "Normal Saline (Placebo)" (2 trials). Other intervention names were less common.

The vast majority of trials in "NYU Hospital for Joint Diseases" are 60 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "NYU Hospital for Joint Diseases". undefined are not yet recruiting, 10 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 37 completed trials in NYU Hospital for Joint Diseases, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in NYU Hospital for Joint Diseases, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 21 trials that are defined as “Not Applicable".